Open-Label, Multi-Center, Non-Interventional Study in Rheumatoid Arthritis (RA) Patients Treated With Tocilizumab SC Monotherapy in Daily Clinical Practice
Phase of Trial: Phase IV
Latest Information Update: 30 Aug 2017
At a glance
- Drugs Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms SIMPACT
- Sponsors Roche
- 23 Aug 2017 Planned number of patients changed from 200 to 350.
- 09 May 2017 Planned End Date changed from 1 Oct 2017 to 26 Feb 2019.
- 09 May 2017 Planned primary completion date changed from 1 Oct 2017 to 26 Feb 2019.